Researchers in Heidelberg unveiled Hetairos, an AI system designed to classify brain tumors using standard histology tissue sections, producing results in minutes rather than weeks for diagnostic turnaround. The approach uses conventional histological stains paired with deep learning. The claim is clinically relevant because pathology workflows are time-intensive and depend on expertise—an area where high-quality, reproducible computer vision tools could reduce variability. The work positions AI as a diagnostic layer that can sit directly on routine lab slides. If validated prospectively, the model could shorten time-to-treatment decisions in neuro-oncology and expand access to consistent tumor classification support.